The QualityStocks Daily Stock List
- US Nuclear Corp. (UCLE)
- Veritas Farms, Inc. (VFRM)
- CleanSpark, Inc. (CLSK)
- FLYHT Aerospace Solutions Ltd. (FLYLF)
- OceanaGold Corporation (OGDCF)
- Patriot One Technologies, Inc. (PTOTF)
- WeedMD, Inc. (WDDMF)
- MGX Minerals, Inc. (MGXMF)
- Dakota Territory Resource Corp. (DTRC)
- Nutra Pharma Corp. (NPHC)
- Purebase Corp. (PUBC)
- SpendSmart Networks, Inc. (SSPC)
- Federal Home Loan Mortgage Corporation (FMCC)
- eWellness Healthcare Corp. (EWLL)
US Nuclear Corp. (UCLE)
Energy Central News, Investing.com. StockPulse, Stock News Now, Market Screener, Seeking Alpha, Stockhouse, Simply Wall St, Stockopedia, and GlobeNewswire reported previously on US Nuclear Corp. (UCLE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, US Nuclear Corp. is a leader in radiation detection. The Company develops, manufactures, and sells radiation detection and measuring equipment worldwide. US Nuclear has 100 plus years of experience providing quality Chemical Radiation Detection and Monitoring Instrumentation. The Company has its corporate office in Canoga Park, California.
US Nuclear provides measurement instrumentation for the nuclear energy industry and for developing technological processes including Fusion, Thorium and Molten Salt (MSR) reactor technologies domestically and globally. American and International customers include United States Government Agencies, the U.S. Military, Homeland Security, National Laboratories, Universities, Hospitals, nuclear reactor facilities in the U.S., China, Canada, South Korea, Argentina, Russia, as well as others.
Via three operating divisions (Technical Associates (TA)), Overhoff Technology (OTC), and Electronic Control Concepts (ECC), the Company supplies top of the line instrumentation to any industry utilizing radionuclides. These industries include nuclear power plants, national laboratories, government agencies, homeland security, military, and universities and schools. In addition, industries include research companies, hospitals, medical and dental centers, energy companies, weapons facilities, first responders, local governments, and manufacturing plants.
Furthermore, US Nuclear engages in Product Development. The newest product development of US Nuclear is the incorporation of radiation and chemical sensors with drone mounted platforms. The Company’s strategic partnership with FlyCFam UAV provides a complete package to a customer that flies in all-weather, heavy winds, and with a heavy payload. This provides the opportunity to fly numerous sensors at one time with real-time wireless download.
US Nuclear has a strategic alliance agreement with QYSEA Technology. This agreement is to market, build, sell, and service Industrial Underwater Robot Sensor Systems in the U.S. and around the world. QYSEA Technology is based in Shenzhen, China and is a world-leading manufacturer of unmanned underwater vehicles (UUV). QYSEA Technology is known for the FIFISH - a professional underwater ROV for inspection, photography, videography, and exploration.
Today, US Nuclear reported a 172 percent increase in Revenue in Q2 2019. Sales for the three months ended June 30, 2019 were $1,530,523. This represents an increase of $968,995 or 172 percent versus the same period last year. Gross profit was $785,933 versus $287,799 for the same period in 2018. This represents an increase of 173 percent.
Net loss from operations was ($466,019). This was because of stock-based compensation as the company acquires new partnerships, technology, sales and marketing consultants, and other services to foster company growth.
US Nuclear Corp. (UCLE), closed Monday's trading session at $0.95, up 26.6667%, on 41,820 volume with 41 trades. The average volume for the last 3 months is 18,498 and the stock's 52-week low/high is $0.202000007/$2.8499999.
Veritas Farms, Inc. (VFRM)
TeleTrader, Alpha Stock News, Direct Cannabis Network, Market Screener, Street Insider, Investors Hangout, Equities, GlobeNewswire, TradingView, and EIN Newsdesk reported earlier on Veritas Farms, Inc. (VFRM), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Veritas Farms, Inc. is a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids. Currently, the Company operates a 140-acre farm and production facilities in Pueblo, Colorado. Veritas is registered with the Colorado Department of Agriculture to grow industrial hemp. Veritas Farms™ brand full-spectrum hemp extract products can be found at many leading online and brick-and-mortar retailers throughout the U.S.
The Company previously went by the name SanSal Wellness Holdings, Inc. It changed its name to Veritas Farms, Inc. in February of 2019. OTCQB-listed, Veritas Farms is based in Fort Lauderdale, Florida.
Veritas produces premier quality, full spectrum CBD (cannabidiol) products from its sustainable farm in Pueblo, Colorado. The Company has developed its own fertilizer, which helps balance out the local ecosystem. Veritas Farms’ commitment is to growing the finest hemp. It accomplishes this by way of a special cultivation process combined with extensive quality control testing.
Veritas utilizes drip irrigation. This ensures every plant gets the proper hydration and that Veritas conserves the Rocky Mountain water it uses. Veritas always cultivates from mother plants instead of growing from seeds. Using clones enables Veritas Farms to maintain genetic stability. Clones are clipped from the mothers and then undergo a rooting process that takes 7 to 14 days. Subsequently, the plants are transferred to pots to begin the vegetative stage. Plants are then harvested and hung or stripped of their leaves and buds for drying. When the proper moisture level is reached, the plants are ground for extraction.
Veritas Farms™ has its full spectrum hemp oil products on the shelves at greater than 4,500 retail locations across the nation. This includes more than 3,500 national chain pharmacy and supermarket outlets. These combined growth factors helped boost its revenues by more than 500 percent from Q2 2018 to Q2 2019.
Veritas Farms has successfully completed two private placement financings over the past 19 months that provided the Company with more than $20 million. The capital infusion is now being deployed to fuel its ongoing efforts to expand its retail distribution network, implement additional sales and marketing programs, expand infrastructure, fill key management and administrative positions, and plan several new category product launches during the balance of this year.
Veritas Farms, Inc. (VFRM), closed Monday's trading session at $1.01, up 4.1237%, on 81,979 volume with 106 trades. The average volume for the last 3 months is 220,028 and the stock's 52-week low/high is $0.200000002/$2.28999996.
CleanSpark, Inc. (CLSK)
Pot Stock News, Wallet Investor, Stockwatch, Barchart, Trading View, Uptick Newswire, PR Newswire, Insider Financial, Micro Cap Daily, Financial Buzz, MarketBeat, Equities, GlobeNewswire, Market Screener, Stockhouse, Simply Wall St, YCharts, InvestorsHub, Dividend Investor, and MarketWatch reported earlier on CleanSpark, Inc. (CLSK), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CleanSpark, Inc. is a microgrid company with advanced engineering, software and controls for inventive distributed energy resource (DER) and microgrid deployments. It provides advanced energy software and control technology that enables a plug-and-play enterprise solution to modern energy challenges. CleanSpark's customers include energy consumers and the distributed energy ecosystem at large: developers, installers, EPCs, IPPs, and energy storage vendors. The Company was formerly known as Stratean, Inc. It changed its name to CleanSpark, Inc. in November of 2016. CleanSpark is headquartered in Utah.
The Company’s services consist of intelligent energy monitoring and controls, microgrid design and engineering, microgrid consulting services, and turn-key microgrid implementation services. CleanSpark's software enables energy users to obtain resiliency and economic optimization. The Company’s software is uniquely capable of enabling a microgrid to be scaled to the user's specific needs. It can be broadly implemented across commercial, industrial, military, agricultural, and municipal deployment.
CleanSpark’s Microgrid Value Stream Optimizer outputs are a client’s customized guide to maximizing their energy project’s ROI (Return on Investment). State-of-the-art data analytics account for real costs, precise utility rate models, equipment performance, and actual energy consumption. They outline what kind of energy resources are to be built, what it will cost, and how it will perform upon deployment.
The Company’s mPulse software is an innovation in controls capable of integrating manifold Distributed Energy Resources (DER). This includes storage, renewables and fossil fuel technologies. CleanSpark’s intelligent software package collects, archives and analyzes data 24/7 providing real-time control and reporting. Concerning Engineering & Grid Development Services, the Company’s mVSO provides critical information. Addition ally, it is the starting point for CleanSpark’s microgrid development services.
Last month, CleanSpark announced the integration of Costa Rican tariffs in its proprietary mVSO (microgrid Value Stream Optimizer) software. The Company’s proprietary mVSO software has integrated many electricity tariffs for the Costa Rican market. Specifically, a number of commercial and industrial tariffs from the Instituto Costarricense de Electricidad (English: Costa Rican Institute of Electricity) (ICE) and Compañia Nacional de Fuerza y Luz (English: National Power and Light Company) (CNFL) that serve most of the country. The integration of Costa Rican tariffs, in conjunction with new implementation details that have augmented mVSO's optimization logic increase mVSO's applicability to new and developing markets.
Mr. Rich Inman, Director of Data Analytics, said, "Integration of a Costa Rican solution is the first step in CleanSpark's longer-term plan to increase our deployment of systems in the greater Central American energy market. In the last four years, Costa Rica has generated over 98 percent of its electricity from renewable sources, which makes the market particularly interesting.”
CleanSpark, Inc. (CLSK), closed Monday's trading session at $0.95, up 2.1505%, on 60,233 volume with 52 trades. The average volume for the last 3 months is 83,950 and the stock's 52-week low/high is $0.76999998/$15.0100002.
FLYHT Aerospace Solutions Ltd. (FLYLF)
Stockhouse, TipRanks, Dividend Investor, Stockwatch, Seeking Alpha, GlobeNewswire, TMX Money, InvestorsHub, and Wallet Investor reported earlier on FLYHT Aerospace Solutions Ltd. (FLYLF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTCQX-listed, FLYHT Aerospace Solutions Ltd.’s mission is to improve aviation safety, efficiency and profitability. Airlines, leasing companies, fractional owners and original equipment manufacturers (OEMs) have installed FLYHT’s differentiated aircraft and enterprise-based solutions to deliver real-time, flight-deck, satellite connectivity for tracking, health monitoring, and streaming of operational, maintenance and weather data. FLYHT Aerospace Solutions is headquartered in Calgary, Alberta. The Company also has an office in Littleton, Colorado.
FLYHT Aerospace’s product family includes Flight Tracking; FDR Streaming; Fuel Management; Iridium Satcom; and FLYHTweather. The Company offers enhanced global flight tracking capabilities that meet and surpass ICAO’s Global Aeronautical Distress and Safety System (GADSS) definitions for normal and abnormal tracking. Moreover, the Automated Flight Information Reporting System (AFIRS™) automates the collection and dissemination of block and flight times.
Furthermore, the FLYHTASD™ is a fully integrated and interactive enhanced global flight tracking solution. It makes tracking the progress and monitoring the status of one’s aircraft seamless. In addition, FLYHTASD comes complete with a completely integrated text messaging interface. This permits operators to send and receive text messages to numerous aircraft at any one time.
The above-mentioned Automated Flight Information Reporting System (AFIRS™) is an Iridium-based SATCOM device installed on the aircraft. It uses the Company’s proprietary software to acquire and transmit aircraft data to the ground in real time. This data is subsequently processed and distributed to the customer using FLYHT’s ground server network called UpTime™.
Q2 2019 highlights for FLYHT Aerospace Solutions include receiving United States Federal Aviation Agency (FAA) Parts Manufacturing Approval for Automated Flight Information Reporting System (AFIRS) products. It also secured an aggregate US $3.0 million in sales contracts and purchase orders, assuming FLYHT provides services over the full term of the contracts. In addition, the Company reported a sales order backlog of greater than $58.0 million.
Last week, FLYHT Aerospace Solutions announced a new partner relationship. FLYHT, along with ATP CaseBank, announced a jointly offered solution to improve aircraft reliability. ATP CaseBank is the foremost provider of troubleshooting, reliability and defect trend analysis solutions.
The two companies will work together to create an application, which will help identify and communicate potential and existing aircraft equipment health issues. This will more effectively allow for better diagnosis and subsequent repair.
The design of the Aircraft Health Monitoring System (AHMS) is to detect, alert, and automatically capture important diagnostics data for all aspects of the aircraft, in real-time. This innovation helps airlines discover issues before they affect the serviceability of the aircraft. This will enable proactive maintenance to avoid future flight delays or cancellations.
FLYHT Aerospace Solutions Ltd. (FLYLF), closed Monday's trading session at $1.1196, off by 0.391459%, on 1,200 volume with 5 trades. The average volume for the last 3 months is 16,587 and the stock's 52-week low/high is $0.670000016/$1.46000003.
OceanaGold Corporation (OGDCF)
TeleTrader, 4-Traders, Seeking Alpha, Forex Stock News, MarketBeat, AASTOCKS.com, Wallmine, Northern Miner, Investing.com, CapitalCube, Resource World, TradingView, and Wallet Investor reported beforehand on OceanaGold Corporation (OGDCF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
OceanaGold Corporation is a multinational gold producer with worldwide operating, development, and exploration experience. The Company’s operating assets include the Didipio Mine on Luzon Island in the Philippines; the Macraes Operations in the South Island of New Zealand; the Waihi Gold Mine in the North Island of New Zealand; and the Haile Gold Mine in South Carolina. OceanaGold has a significant pipeline of organic growth and exploration opportunities in the Americas and Asia-Pacific. The Company has a track record of converting discoveries into production.
OceanaGold has its head office in Melbourne, Australia. The Company’s business is supported by its Americas office in Denver, Colorado; a technical and projects office in Brisbane, Australia; and an information technology (IT) and finance office in Singapore. OceanaGold’s shares trade on the OTC Markets.
OceanaGold developed out of the gold-production assets of Gold and Resource Developments Limited in 2003 with a diverse portfolio of assets in the South Island of New Zealand. In 2006, the Company acquired the Didipio Project in the Philippines through the merger with Climax Mining. In 2015, OceanaGold expanded its presence in New Zealand with the acquisition of the Waihi Gold Mine in the North Island, and also took ownership of the Haile Gold Mine through the takeover of Romarco Minerals, Inc. Furthermore, OceanaGold made a strategic investment in Gold Standard Ventures.
OceanaGold started a Joint Venture (JV) with Renaissance Gold this year for the Spring Peak and Fat Lizard gold projects in Nevada. The Company also received permits for Martha Underground Expansion project at Waihi. It also reported an initial high-grade resource for the Wharekirauponga Exploration Project in New Zealand. Additionally, it started a JV with American Pacific Mining Corp. for the Tuscarora Gold Project in Nevada, and started a JV with Rio de Oro S.A. for the Pedernales and Santa Teresita projects in Argentina.
On July 21, 2019, OceanaGold’s Macraes Operations in the South Island of New Zealand celebrated the five millionth ounce of gold poured at the operation. OceanaGold has undertaken 28,000 meters of exploration drilling at Macraes in the first half of this year.
Recently, OceanaGold reported its Q2 2019 financial and operational results for the quarter ended June 30, 2019. Selected highlights include major improvement of the Haile operations with a quarter-on-quarter production increase of 45 percent, a unit cash cost decrease of 39 percent, and an All-In Sustaining Costs (AISC) decrease of 23 percent; despite accelerated pre-stripping activities.
The Company had first half of 2019 consolidated production of 254,972 ounces of gold and 7,871 tonnes of copper. This includes Q2 production of 129,290 ounces of gold and 3,961 tonnes of copper. First half 2019 consolidated All-In Sustaining Costs (AISC) were $1,073 per ounce on sales of 246,753 ounces of gold and 6,921 tonnes of copper..
OceanaGold had first half revenue of $365.5 million with Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) of $135.1 million and a net profit of $27.7 million. Q2 revenue was $186.0 million with EBITDA of $70.7 million and a net profit of $15.3 million.
OceanaGold Corporation (OGDCF), closed Monday's trading session at $2.41, up 1.7565%, on 1,860 volume with 5 trades. The average volume for the last 3 months is 1,886 and the stock's 52-week low/high is $2.20300006/$3.74.
Patriot One Technologies, Inc. (PTOTF)
NetworkNewsWire, Insider Financial, Streetwise Reports, Micro Small Cap, Playstocks, Profit Confidential, Midas Letter, and Stockhouse reported previously on Patriot One Technologies, Inc. (PTOTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
A technology enterprise, Patriot One Technologies, Inc. engages in the research, development, and commercialization of a system to detect concealed weapons using radar technologies. The Company’s mission is to be the top global solutions provider for public safety. It works to deliver unique threat detection and counter-terrorism solutions for safer communities. Patriot One Technologies is headquartered in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQX.
The Company aims to address the spread of active violence through superior detection technology that immediately identifies concealed weapons. Its PATSCAN™ Multi-Sensor Covert Threat Detection Platform provides a network of advanced sensor technologies with powerful next generation AI/machine learning software. This network can be covertly deployed from far perimeter to interiors across manifold weapons-restricted facilities.
The PATSCAN™ platform identifies and reports threats wherever required; car park, building approach, employee & public entryways, as well as inside the facilities. Each solution in the platform identifies weapons, related threats, or disturbances for immediate security response.
Patriot One Technologies is commercializing its PATSCAN™ CMR technology as an automated alert system capable of covertly screening moving individuals for on-body concealed weapons. This includes handguns, knives, grenades, explosive vests, and more.
Today, Patriot One Technologies announced the acquisition of XTRACT Technologies, Inc. and all its related interests, assets, and intellectual property (IP) for consideration of $6,000,000 and the issuance of 9,422,956 Patriot One common shares to XTRACT’s former shareholders. This Transaction follows demonstrated success of an ongoing collaborative project between the two companies that was announced in late July of this year.
As a wholly-owned subsidiary, XTRACT will continue to operate as its own business unit and under its present brand name. XTRACT develops and commercializes artificial intelligence (AI), machine learning, deep neural network, and predictive solutions employing its proprietary technology for public institutions and private enterprise.
Patriot One Technologies, Inc. (PTOTF), closed Monday's trading session at $1.345, off by 0.362768%, on 82,269 volume with 96 trades. The average volume for the last 3 months is 97,330 and the stock's 52-week low/high is $1.14999997/$2.28999996.
WeedMD, Inc. (WDDMF)
CannabisMarketCap, OTC Markets, Pot Stock News, Micro Small Cap, Financial Insiders, Marijuana Stock Review, Daily Marijuana Observer, Stock Day Media, Profit Confidential, The Cannabis Investor, Investor Ideas, New Cannabis Ventures, Financial Buzz, Micro Small Cap, Midas Letter, Morningstar, and Stockwatch reported beforehand on WeedMD, Inc. (WDDMF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
WeedMD, Inc. is a federally-licensed producer and distributor of medical-grade cannabis. It is the publicly-traded parent company of WeedMD Rx, Inc., a federally-licensed producer and distributor of cannabis products for the medical and adult-use markets. WeedMD has a multi-channeled distribution strategy. This includes selling directly to medical patients, strategic relationships across the seniors’ market, and supply agreements with Shoppers Drug Mart and also six provincial distribution agencies. OTCQX-listed, WeedMD is headquartered in Aylmer, Ontario.
WeedMD owns and operates two facilities. One is a 26,000 sq. ft. facility in Aylmer, Ontario. The other is a 158-acre state-of-the-art greenhouse and outdoor facility in Strathroy, Ontario. Currently, the Company has 136,000 square feet of licensed indoor and greenhouse production space across its facilities.
The expectation is that it will have a total footprint of more than 550,000 square feet of indoor and greenhouse production space online in 2019. In addition, 27 acres of outdoor cultivation has now been approved for cultivation. First harvest is expected this autumn. The Aylmer facility currently produces premium indoor flower.
WeedMD has launched Color™ Cannabis. Color Cannabis was developed specifically for a diverse adult-use market that reflects the range in tastes and preferences of modern cannabis consumers. Color Cannabis products include a variety of strains, in many formats, developed with first-rate quality cannabis. Color Cannabis is a premium brand exclusively available to distributors and select retailers across Canada.
Along with premium dried flower, Color Cannabis will launch new product formats in the coming months. These include pre-rolls, oils, and gel capsules with further consumption formats in development. Color will offer up to 10 unique strains from WeedMD’s proprietary genetics collection.
In August, WeedMD announced that 40 of its medical cannabis strains were included in the completion of the first phase of TruTrace Technologies’ (formerly BLOCKStrain Technology Corp.) medical cannabis verification pilot project with Shoppers Drug Mart. As recently announced by the companies, together with Deloitte Canada LLP, Phase 2 of the Pilot Project is targeted for completion in late November of this year.
Built on TruTrace Technologies’ proprietary StrainSecure™ system that focuses on cannabis product testing and verification to confirm origin, authenticity and quality, WeedMD is the first and only licensed producer to have 40 strains registered in the program. The technology helps in the protection of WeedMD’s innovative strains. The technology also assists its customers, including Shoppers Drug Mart, with strain and product authenticity.
WeedMD, Inc. (WDDMF), closed Monday's trading session at $1.12, even for the day, on 77,369 volume with 97 trades. The average volume for the last 3 months is 76,077 and the stock's 52-week low/high is $0.728299975/$1.95000004.
MGX Minerals, Inc. (MGXMF)
Proactive Investors, Wall Street PR, InvestorsHub, Wallet Investor, Dividend Investor, Stockhouse, OTC Markets, MarketWatch, 4-Traders, Morningstar, Capital Equity Review, The Street, Stockwatch, Equities, StockInvest.us, The Streetwise Reports, Barchart, and Market Screener reported previously on MGX Minerals, Inc. (MGXMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MGX Minerals, Inc. is a diversified resource company with its corporate headquarters in Vancouver, British Columbia. It centers on the development of large-scale industrial mineral portfolios in specific commodities and jurisdictions that will fuel the new energy economy. MGX Minerals controls considerable interest in lithium, magnesium and silicon assets throughout North America. The Company lists on the OTC Markets Group’s OTCQB.
MGX Minerals’ strategy is to identify commodities and jurisdictions where large-scale development opportunities exist. Additionally, the Company’s strategy is to build its asset portfolio via aggressive acquisition to quickly build and enhance long-term portfolio value. Furthermore, its strategy is to engage industry experts to lessen execution risk and quickly increase time to market.
The Company has regional control in most of the industrial mineral projects in the jurisdictions it operates. Pertaining to near-term potential, MGX Minerals concentrates on assets that offer streamlined development timelines and low initial capital expenditures (capex). It has developed a proprietary, low-energy design process (Rapid Recovery Process) that is patent-pending. The design of it is specifically for highly-mineralized brine associated with oilfields. The process quickly concentrates lithium and other minerals in brine.
MGX Minerals has completed pilot plant testing in South America on brine samples originating from numerous salars in Chile. The Company entered into a joint brine testing agreement with several South American mining companies. The parties are working to identify potential joint-venture (JV) locations that will utilize MGX Minerals’ lithium extraction technology.
Recently, MGX Minerals and engineering partner PurLucid Treatment Solutions reported that a second deployment of an advanced wastewater treatment system is near completion and commissioning is anticipated soon. This system is capable of processing up to 10m3 per hour. The system will substantially decrease greenhouse gases through energy savings on steam generation. The technology provides superior treatment outcomes versus conventional technology that requires offsite trucking and high cost (because of toxicity) disposal. PurLucid Treatment Solutions’ exclusively licensed and patented nanoflotation technology was designed purposely for oilfield environments.
MGX Minerals also recently reported that its collaborative research partnership with the University of British Columbia (UBC) completed a wide-ranging baseline assessment of metallurgical silicon originating from each of MGX’s three silicon projects in southeastern British Columbia. The Company and UBC are working together to develop next-generation Li-ion batteries capable of quadrupling energy density from present 100 Wh/kg up to 400 Wh/kg for use in long-range electric vehicles and grid storage.
MGX Minerals, Inc. (MGXMF), closed Monday's trading session at $0.160485, up 31.5559%, on 245,486 volume with 61 trades. The average volume for the last 3 months is 90,160 and the stock's 52-week low/high is $0.110100001/$0.628600001.
Dakota Territory Resource Corp. (DTRC)
InvestorsHub, Zacks, Market Screener, YCharts, TradingView, Stockhouse, Barchart, Simply Wall St, Uptick Newswire, Real Investment Advice, Innovative Marketing, OTC Markets Group, Ultimate Penny Stock, MarketWatch, The Street, Marketbeat, Dividend Investor, last19k, Wallet Investor, Corporate Information, and 4-Traders reported earlier on Dakota Territory Resource Corp. (DTRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Dakota Territory Resource Corp.’s emphasis is on the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. The Company maintains 100 percent ownership of three gold properties encompassing roughly 4,059 acres. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All of these properties are in the heart of the Homestake District. OTCQB-listed, Dakota Territory Resource is headquartered in Reno, Nevada.
The Company’s flagship property is the Blind Gold Property, which is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is about four miles northwest and on structural trend with the historic Homestake Gold Mine.
The Homestake Gold Mine produced roughly 40 million ounces of gold through its 125-year production history. It is the largest iron-formation-hosted gold deposit in the world.
Dakota Territory’s plan is to continue its sampling program along trend of the zone of high grade gold mineralization identified by the first pass surface sampling program conducted on its 100 percent owned Blind Gold Property. The program identified a zone of high-grade gold mineralization in the Mississippian-age Pahasapa Limestone on the surface, with a peak gold assay value of 9.44 grams per tonne.
The Homestake Paleoplacer Property consists of 13 unpatented lode mining claims. These are situated one-mile north of the Homestake Open Cut. Dakota based the acquisition of its Black Hills property position on more than 44 years of combined mining and exploration experience in the Homestake District.
The Company’s City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek consists of 21 unpatented lode mining claims. These are positioned one-mile northeast of the Homestake Open Cut and one-mile northwest of the City of Deadwood.
Recently, Dakota Territory Resource announced the appointment of Mr. Lee Graber to the Company’s Strategic Advisory Committee. Mr. Graber has more than four decades of experience in the mining industry. This includes 23 years with Homestake Mining Company, one of the largest gold mining companies in the U.S. until it was acquired in 2002 by Barrick Gold Corporation.
As Homestake's Vice President responsible for corporate development, Mr. Graber initiated, managed, and closed manifold joint venture agreements, major acquisitions, and divestment transactions. After Homestake, Mr. Graber served as Managing Director, Mergers and Acquisitions, for Endeavour Financial Ltd.
Dakota Territory Resource Corp. (DTRC), closed Monday's trading session at $0.107, up 25.8824%, on 13,884 volume with 4 trades. The average volume for the last 3 months is 19,334 and the stock's 52-week low/high is $0.019999999/$0.191750004.
Nutra Pharma Corp. (NPHC)
Serious Traders, PennyStocks24, StocksToBuyNow, Pumps and Dumps, Winston Small Cap, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, UndiscoveredEquities, Wallstreetlivechat, and Innovative Marketing reported earlier on Nutra Pharma Corp. (NPHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Nutra Pharma Corp. is a biotechnology company listed on the OTC Markets. The Company specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Nutra Pharma is marketing Nyloxin® and Pet Pain-Away™ in the Over-the-Counter (OTC) pain management market. Founded in 2000, Nutra Pharma is based in Coral Springs, Florida.
By way of its subsidiaries, the Company carries out basic drug discovery research and clinical development. The focus of its approach to drug discovery and the development of new therapeutic agents are based on specialized receptor-binding proteins found in nature, particularly those found in snake venom from the cobra.
Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN. Its MS drug RPI-78M was earlier granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. Nutra Pharma’s RPI-MN inhibits the entry of many viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).
Additionally, Nutra Pharma looks for strategic licensing partnerships to reduce the risks associated with the drug development process. The Company’s holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS.
Nutra Pharma’s Designer Diagnostics subsidiary engages in the research and development (R&D) of diagnostic test kits designed to be used for the quick identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).
Nutra Pharma offers several drug products for sale for pain treatment. One is Nyloxin®, the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The Company has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Another product is Nyloxin Extra Strength. This is the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Moreover, the Company has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.
In September 2018, Nutra Pharma announced that its work with EuroAmerican IP, LLC resulted in a listing of its Nyloxin® product line on the website, www.GoVets.com. GoVets is the online marketplace under the National Veteran Small Business Coalition (NVSBC) to buy from VA-verified Service-Disabled Veteran-Owned Small Businesses (SDVOSBs).
With growing concern regarding consumers using opioid and acetaminophen-based pain relievers, Nyloxin® offers an alternative, which does not rely on opiates or non-steroidal anti-inflammatory drugs, known as NSAIDs, for their pain relieving effects. Nyloxin® has a well-defined safety profile.
Nutra Pharma Corp. (NPHC), closed Monday's trading session at $0.0004, up 33.3333%, on 500,303 volume with 5 trades. The average volume for the last 3 months is 3,612,964 and the stock's 52-week low/high is $0.000099999/$0.000799999.
Purebase Corp. (PUBC)
InvestorsHub, MarketWatch, 4-Traders, OTC Markets, and Stockhouse reported previously on Purebase Corp. (PUBC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Purebase Corp. centers on delivering high quality organic mineral products for the agricultural sector. A diversified, natural, and industrial mineral resource enterprise, the Company concentrates on the acquisition, development, mining, and marketing of industrial and natural mineral properties in California, Nevada, and the rest of the U.S. as its chief priority. Purebase has its headquarters in Ione, California and the Company’s shares trade on the OTC Markets’ OTCQB.
Purebase has created Purebase Networks. This is an AgTech startup. Purebase Networks concentrates on combining Internet of Things (IoT) agricultural sensors, wireless networking, and also cloud technologies to deliver the industry's first vertically integrated agricultural supply chain.
Purebase Networks will partner with Purebase Corp. to deliver proprietary, organic soil amendments for farmers. Purebase Networks will also provide farmers with access to Purebase Networks' proprietary "Big Data" analytics. This is to provide more visibility into crop and soil performance.
Pertaining to the agriculture industry, Purebase provides soil amendment and fertilizer solutions, which are of major benefit to large commercial farming operations and retail consumer markets. Purebase Grow is a total family of soil amendment products.
Grow products include Purebase Humate Advantage; Purebase Potassium & Sulfate Advantage; Purebase Soil Advantage; Purebase Shade Advantage; and Purebase Fulvic Advantage. The focus of these products is to provide a better, more natural way to grow, manage, and increase yield on the farm and deliver higher quality products to consumers’ tables.
Concerning the construction industry, Purebase provides a Supplementary Cementitious Material (SCM). This is an additive that may be used in cement for large infrastructure construction projects for government, commercial, and residential buildings. Purebase Build SCM appreciably lessens greenhouse gas emissions and harmful particulate matter. Moreover, it reduces the overall cost of concrete. This is while increasing its strength.
Regarding its facilities and properties, the Company’s focus is on the commercialization of its three green mining properties. It owns two pozzolan projects, one in Northern California, and the other in Southern California. These serve the regions’ primary markets for the agricultural and construction sectors. Purebase’s potassium-sulfur project is in south-central Nevada near the Company’s central valley agricultural market.
Purebase Corp. (PUBC), closed Monday's trading session at $0.20, up 37.931%, on 4,890 volume with 8 trades. The average volume for the last 3 months is 9,247 and the stock's 52-week low/high is $0.020999999/$0.500100016.
SpendSmart Networks, Inc. (SSPC)
Marketbeat.com and Flagler Financial Group reported on SpendSmart Networks, Inc. (SSPC), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, SpendSmart Networks, Inc. does business as (d/b/a) SMS Masterminds (SMS). The Company provides proprietary loyalty systems and a collection of digital engagement and marketing services. These help local merchants build relationships with consumers and grow revenues. The Company formerly went by the name The SpendSmart Payments Company, Inc. It changed its name to SpendSmart Networks, Inc. in June 2014. SpendSmart Networks has its headquarters in San Luis Obispo, California.
At present, the Company delivers and manages loyalty platforms. These include merchant funded rewards; loyalty rewards tablet/kiosk, as well as proprietary rewards management systems. In addition, it delivers and manages mobile marketing technology. This includes text and email messaging, customer analytics and propensity marketing, patent pending automated engagement engine, and Text2Win sweepstakes features.
SpendSmart Networks is a specialist in Mobile. It assists local businesses in finding new customers, and turn existing customers into digital advocates. The Company will optimize a client’s website, produce more reviews, and get a client’s customers to return more frequently via SpendSmart’s loyalty and text message marketing strategies.
Furthermore, SpendSmart Networks delivers and manages enterprise level loyalty and mobile marketing consulting. This consists of monthly hands on reviews by its Certified Masterminds, campaign creation and optimization, and localized support.
The Company also provides mobile and loyalty marketing services for small and medium sized businesses. Additionally, it provides personalized Website, e-commerce, and mobile application (app) development services; and Web marketing tools and analytics.
Consumers' dollars go further when they spend it with merchants in the SpendSmart network of merchants. This is because they receive exclusive deals, earn rewards, and in due time build a connection with their favorite merchants.
SpendSmart Networks services are implemented and supported by an extensive network of certified digital marketing specialists (Certified Masterminds) who grow revenue and consumer relationships for merchants through loyalty programs, mobile marketing, and website development.
In October of 2017, SpendSmart Networks announced that it entered into a purchase agreement to sell its operational assets to Eclipse Marketing, LLC. The sale will permit the Company to decrease its ongoing monthly expenses and also improve its debt structure.
After this transaction, SpendSmart Networks’ intention is to find an existing private company to merge into its public entity.
Mr. Luke Wallace, SpendSmart Networks’ Chief Executive Officer, said in October, "This transaction provides the company with its best opportunity to clean its balance sheet and merge with a new company that has a strong potential for growth."
SpendSmart Networks, Inc. (SSPC), closed Monday's trading session at $0.0005, up 49,900%, on 250,020 volume with 4 trades. The average volume for the last 3 months is 325 and the stock's 52-week low/high is $0.002/$0.007199999.
Federal Home Loan Mortgage Corporation (FMCC)
Investing.com, MarketWatch, Morningstar, 4-Traders, Capital Cube, and StockInvest.us reported on Federal Home Loan Mortgage Corporation (FMCC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Federal Home Loan Mortgage Corporation (also known as Freddie Mac) provides mortgage capital to lenders. Freddie Mac was created by Congress in 1970. It makes home possible for homebuyers, homeowners and renters across the nation. Federal Home Loan Mortgage Corporation (FMCC) is headquartered in McLean, Virginia. The Company’s shares trade on the OTC Markets Group’s OTCQB.
FMCC’s mission is to provide liquidity, stability, and affordability to the U.S. housing market in all economic conditions. FMCC operates in the secondary mortgage market. FMCC keeps mortgage capital flowing through purchasing mortgage loans from lenders so they subsequently can provide more loans to qualified borrowers.
Fundamentally, FMCC purchases residential mortgage loans originated by lenders, and also invests in mortgage loans and mortgage-related securities.
The Company’s business lines include Single-Family – supports homebuyers and homeowners; Multifamily – supports renters; and Capital Markets - manages its investment portfolio. FMCC has made home possible close to 77 million times since 1970.
In 2017, FMCC provided $429 billion in mortgage funding. In addition, FMCC’s total guarantee portfolio grew to $2 trillion in 2017. Furthermore, the Company reported $5.6 billion in Net Income in 2017.
Recently, FMCC released the results of its Primary Mortgage Market Survey® (PMMS®). It shows the 30-year fixed mortgage rate increasing for the eighth-consecutive week.
The 30-year fixed-rate mortgage (FRM) averaged 4.43 percent with an average 0.5 point for the week ending March 1, 2018. This is up from last week when it averaged 4.40 percent. A year prior at this time, the 30-year FRM averaged 4.10 percent.
The 15-year FRM this week averaged 3.90 percent with an average 0.5 point. This is up from last week when it averaged 3.85 percent. A year prior at this time, the 15-year FRM averaged 3.32 percent.
The 5-year Treasury-indexed hybrid adjustable-rate mortgage (ARM) averaged 3.62 percent this week with an average 0.4 point. This is down a bit from last week when it averaged 3.65. A year prior at this time, the 5-year ARM averaged 3.14 percent.
Federal Home Loan Mortgage Corporation (FMCC), closed Monday's trading session at $3.67, up 42.8016%, on 32,544,871 volume with 11,110 trades. The average volume for the last 3 months is 1,854,441 and the stock's 52-week low/high is $0.980000019/$3.74.
eWellness Healthcare Corp. (EWLL)
Penny Stock Prodigy and StockHideout reported earlier on eWellness Healthcare Corp. (EWLL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Culver City, California-based eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients via contracted physician practices and healthcare systems. The Company has launched PHZIO. The design of this telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine enterprise to provide insurance reimbursable real-time distance monitored treatments. eWellness Healthcare lists on the OTC Markets Group’s OTCQB.
The Company’s business model is to license its PHZIO platform to any physical therapy (PT) clinic in the United States and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program. eWellness Healthcare’s PHZIO is a Physical Therapy Telemedicine platform. It extends a traditional practice online.
The chief features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. In addition, main features include integrated billing, patient metrics, and user administration & customization.
Moreover, PHZIO scales a practice’s billable rates. It also provides tools to make growing a business easier. Pertaining to the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Furthermore, it’s a total on-line PT telemedicine intervention system.
eWellness Healthcare has launched a PHZIO PT clinic on-boarding website. The site includes a telehealth profitability calculator to illustrate to prospective PT clinics the additional profits they can make through using the PHZIO platform.
eWellness Healthcare anticipates adding Artificial Intelligence (AI) tools and predictive analytics into its PHZIO platform by the end of this year. The anticipation is that the new AI and predictive analytics will combine the Company’s existing remote monitoring capabilities with machine learning and intelligent analytics, which take advantage of patient health data to improve healthcare outcomes.
Evolution Physical Therapy has added eWellness Healthcare's Telehealth PT Services at its four clinical locations in Los Angeles, California. This includes Culver City, Playa Vista, Beverly Hills, and Brentwood. Mr. Darwin Fogt, Chief Executive Officer of eWellness Healthcare, owns Evolution Physical Therapy.
Recently, eWellness Healthcare and Total Release Physical Therapy announced an Integration & Marketing Agreement. Total Motion Release Seminars (TMR) is a proprietary physical therapy methodology developed by Mr. Tom Dalonzo-Baker, MPT. TMR is a full-body oriented assessment and treatment approach. TMR helps patients lessen their pain and impairments which limit their function. The treatment approach is created to allow physical therapists to interact and treat their patients remotely. The expectation is that integration with PHZIO will be extensively adopted within the TMR community.
eWellness Healthcare Corp. (EWLL), closed Monday's trading session at $0.07, up 18.8455%, on 2,734,831 volume with 140 trades. The average volume for the last 3 months is 500,120 and the stock's 52-week low/high is $0.045000001/$0.338999986.
The QualityStocks Company Corner
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- SRAX Inc. (NASDAQ: SRAX)
- Trxade Group Inc. (TRXD)
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
- SinglePoint, Inc. (SING)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- Cannabis Strategic Ventures, Inc. (NUGS)
- ChineseInvestors.com (CIIX)
- VPR Brands, LP (VPRB)
- Endonovo Therapeutics Inc. (ENDV)
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) recently released its unaudited financial and operational results for the quarter and half-year ended June 30, 2019. The company was able to achieve strong results despite the competitive landscape of the California cannabis market. Also today, the company reported that Jake Heimark, CEO and Board Member, will present live at VirtualInvestorConferences.com on September 12th. https://tinyurl.com/0912CannabisVICAgenda.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Monday's trading session at $3.4025, up 4.6923%, on 15,025 volume with 54 trades. The average volume for the last 3 months is 37,281 and the stock's 52-week low/high is $2.51999998/$6.00810003.
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Strong Q2 2019 Financial, Operational Results
- Plus Products To Webcast Live At VirtualInvestorConferences.com On September 12th
- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th
SRAX Inc. (NASDAQ: SRAX)
SRAX, Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announces it has entered into new partnerships with major consumer packaged goods (CPG) brands to launch BIG Rewards™, a new feature of SRAX's consumer-managed data marketplace, BIGtoken. BIG Rewards™ enables marketers to engage BIGtoken's nearly 16 million users to participate in brand research and exclusive offers, effectively expanding BIGtoken's commercial capabilities, and solving data problems across the digital marketing and advertising industry.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $2.99, up 0.673401%, on 18,513 volume with 245 trades. The average volume for the last 3 months is 107,980 and the stock's 52-week low/high is $1.54999995/$5.8499999.
- SRAX Partners with Major CPG Brands to Launch New BIGtoken Feature, BIG Rewards™
- SRAX Inc. (NASDAQ: SRAX) is “One to Watch”
- SRAX Inc. (NASDAQ: SRAX) on Leading Edge of New Data Economy with Proprietary BIGtoken Consumer Data Platform
Trxade Group Inc. (TRXD)
Trxade Group Inc. (TRXD) was featured today in a report by NetworkNewsWire. The ever-increasing costs involved in providing for people’s health care needs have created strong political undercurrents in recent years, as exemplified in the United States by the Patient Protection and Affordable Care Act of 2010 and its oft praised and reviled nickname, Obamacare. The act required all Americans to get health insurance or pay a tax, while also making it easier to do so, but it drew the ire of ‘less government’ conservatives, who succeeded in repealing the mandatory enrollment clause nearly a decade later, in turn creating concerns about insurer insolvency as healthy patients drop out of care plans (http://nnw.fm/yVIp0).
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Monday's trading session at $1.20, up 20.00%, on 400 volume with 1 trade. The average volume for the last 3 months is 3,687 and the stock's 52-week low/high is $0.230000004/$1.20000004.
- Trxade Group Inc. (TRXD) Providing Bulwark of Small Pharmacy Security Amid Challenging Health Care Times
- Trxade Group Inc. (TRXD) Empowering Small, Independent Pharmacies
- Trxade Group Inc. (TRXD) Helps Keep Lifeblood of Nation’s Independent Pharmacies Flowing
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
Siyata Mobile Inc. ("Siyata") (TSX-V:SIM / OTCQX:SYATF) is pleased to announce that the Company has completed software integration and has received its first purchase order to commence large scale device trials in the field with a global ridesharing company.
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.
Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.
Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.
The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.
Siyata is headquartered in Montréal, Québec, Canada.
Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.
The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.
The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.
CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.
Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.
CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.
Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.
Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.3457, up 6.879%, on 194,635 volume with 31 trades. The average volume for the last 3 months is 45,786 and the stock's 52-week low/high is $0.288599997/$0.446249991.
- Siyata Mobile Starts Large-Scale Trial with Global U.S. Ridesharing Company
- Siyata Mobile Wins Major Contract from Leading Canadian Heavy Construction Company for UV350 In-Vehicle Smartphone
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Completes $3M Non-Brokered Private Placement; Announces Filing of Q2 Financials, Upcoming Conference Call
SinglePoint, Inc. (SING)
SinglePoint, Inc. (SING) was featured today in a special edition of the Cleantech and Climate Change podcast from Investorideas.com, made up of a series of interviews with thought leaders and C-level management discussing the growth in solar for 2019 and beyond http://ibn.fm/xqKoH. Also today, NetworkNewsWire released a report on the company detailing how SING recently announced that its second quarter 2019 saw incredible revenue earnings of more than double those of the same quarter of last year.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Monday's trading session at $0.0127, up 0.793651%, on 2,220,220 volume with 68 trades. The average volume for the last 3 months is 2,722,475 and the stock's 52-week low/high is $0.009999999/$0.041000001.
- Thought Leaders Discuss Solar’s Success Story – Better Applications, New Relationships and a Cleaner Planet
- SinglePoint Inc. (SING) More than Doubles Revenues in Q2 2019
- SinglePoint to Present Hemp Cigarettes at National Association of Convenience Stores (NACS) Exhibition, Over 23,000 Attendees, Booth 5653
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), today announced that its wholly-owned subsidiary, 7ACRES has launched a proprietary strain; Jack Haze.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $1.08, even for the day, on 340,412 volume with 413 trades. The average volume for the last 3 months is 510,339 and the stock's 52-week low/high is $0.850000023/$2.03999996.
- Supreme Cannabis' High End Brand, 7ACRES, Launches New Cultivar: Jack Haze
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Continues to Expand Global Footprint
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Fortifies Global Position via Truverra Acquisition
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its receipt of Health Canada approval, effective September 6, 2019, for the licensing of 17 additional cultivation rooms under the Cannabis Regulations. To view the full press release, visit: http://nnw.fm/zWb40.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $4.71, off by 4.6559%, on 1,086,142 volume with 4,394 trades. The average volume for the last 3 months is 954,822 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval to Bring Moncton Facility’s Annualized Licensed Capacity to 76,000 kg Target
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval to Bring Moncton Facility’s Annualized Licensed Capacity to 76,000 kg Target
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Gains Media Attention Following Four Profitable Quarters
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce that, as of the opening of the markets today, its class A subordinated voting shares will begin trading on the Toronto Stock Exchange (the "TSX") under the ticker symbol "RIV". This milestone was achieved within less than one year of Canopy Rivers' initial go-public transaction. No further action is required by existing shareholders. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Recently, the city of Los Angeles launched a major crackdown on illegal marijuana activities that include cultivation, extraction, manufacturing and delivery. The city has a penalty of six months’ incarceration and a fine of $1,000 for those convicted of engaging in any unlicensed commercial cannabis activity. Additionally, the company was featured in today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts. http://ibn.fm/MBqyM.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Monday's trading session at $1.87, off by 1.5789%, on 141,340 volume with 319 trades. The average volume for the last 3 months is 116,053 and the stock's 52-week low/high is $1.60000002/$7.30155992.
- Canopy Rivers Begins Trading on the Toronto Stock Exchange
- 420 with CNW – LA Launches Crackdown on Marijuana Black Market
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, and Caliper Foods (formerly Stillwater Foods), a best-in-class provider of water-soluble cannabinoid products, are pleased to unveil the results of a preliminary human pharmacokinetic ("PK") study of Caliper CBD, Caliper Foods' proprietary tasteless and odourless water-soluble powder that can be added to almost any food or beverage. Additionally, the company was featured in today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts http://ibn.fm/WhbOv.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $2.10, off by 7.8947%, on 927,317 volume with 1,275 trades. The average volume for the last 3 months is 743,226 and the stock's 52-week low/high is $1.60699999/$7.89379978.
- The Green Organic Dutchman and Caliper Foods Report Positive Results from Pharmacokinetic Study of Proprietary Water-Soluble Cannabinoid Technology
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Strongly Positioned to Meet Growing Demand for Organic Cannabis
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Investorideas.com, examining how, in a recent sector news it's been reported that Nevada's cannabis industry has given more than $100 million in taxes and fees to the state for the first time since recreational marijuana became legal in 2017.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $1.39, off by 1.0324%, on 184,163 volume with 283 trades. The average volume for the last 3 months is 309,555 and the stock's 52-week low/high is $1.12569999/$5.20499992.
- Cannabis Stocks Sector Snapshot - Viva Las Vegas - Industry Growth In Nevada
- Green Growth Brands Completes Private Placement of Units
- One of the Hottest Cannabis Growth Stories in the World
Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)
Cannabis Strategic Ventures, Inc. (NUGS) was featured today in the 420 with CNW by CannabisNewsWire. Recently, the city of Los Angeles launched a major crackdown on illegal marijuana activities that include cultivation, extraction, manufacturing and delivery. The city has a penalty of six months’ incarceration and a fine of $1,000 for those convicted of engaging in any unlicensed commercial cannabis activity.
Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Monday's trading session at $0.329, off by 0.27281%, on 84,013 volume with 52 trades. The average volume for the last 3 months is 97,055 and the stock's 52-week low/high is $0.25/$4.84000015.
- 420 with CNW – LA Launches Crackdown on Marijuana Black Market
- 420 with CNW – Missouri Receives More than 2,100 Medical Marijuana Business Applications
- Cannabis Strategic Ventures Harvests First Cannabis Crop and provides an update on Strategic Investment Partner
Premier financial news and education provider ChineseInvestors.com Inc. (OTCQB: CIIX) this morning announced that its subsidiary, CBD Biotech Inc., has launched six new products in conjunction with its long-term strategic plans to expand its presence in the hemp/CBD skincare market. To view the full press release, visit http://nnw.fm/G0yle.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Monday's trading session at $0.31275, off by 2.1127%, on 71,238 volume with 40 trades. The average volume for the last 3 months is 45,632 and the stock's 52-week low/high is $0.27000001/$1.25.
- ChineseInvestors.com Inc. (CIIX) Announces Subsidiary’s Launch of Six New Hemp-Infused Skincare Offerings
- ChineseInvestors.com Inc. (CIIX) Announces Sales Up 175% in Fiscal Year 2019
- California Solar Market Helps Cannabis Industry, Sees More Takeovers: Solar Integrated Roofing Completes Another Acquisition, Adding $5M+ to Annual Revenues
VPR Brands, LP (VPRB)
VPR Brands LP (OTCQB: VPRB), a multi-tiered technology holding company in the cannabis and vaping verticals, has detailed plans to debut a JUST Batteries vape line in collaboration with Just CBD, a leading player in the CBD space (http://nnw.fm/D03ff). VPRB also plans to relaunch its popular KRAVE brand of e-cigarettes with a salt-nicotine, disposable-pod vaporizer unit (http://nnw.fm/Sq0Qu).
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Monday's trading session at $0.0599, off by 18.0575%, on 242,725 volume with 25 trades. The average volume for the last 3 months is 217,980 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- VPR Brands LP (VPRB) Readies for Q3 Debut of JUST Batteries Vape Line, Relaunch of KRAVE E-Cigarettes
- 420 with CNW – Colombia Makes Progress as an International Medical Marijuana Industry Player
- VPR Brands LP (VPRB) Positioned to Experience Windfall as Thai Hospitals Start Administering Cannabis Oils
Endonovo Therapeutics Inc. (ENDV)
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announces a partnership with Veterans Healthcare Supply Solutions to initiate SofPulse® sales to Veterans Health Administration and military hospitals. The Company additionally announces the appointment of Dr. Sam Awad to its scientific advisory board.
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Endonovo Therapeutics Inc. (ENDV), closed Monday's trading session at $0.0081, off by 11.9565%, on 5,887,310 volume with 91 trades. The average volume for the last 3 months is 4,219,288 and the stock's 52-week low/high is $0.0081/$0.066100001.
- Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board
- Endonovo Therapeutics Inc. (ENDV) Planning Nationwide Rollout of Pain-Management Device
- Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) CEO Rings Nasdaq Opening Bell
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Missouri Receives More than 2,100 Medical Marijuana Business Applications
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Gains Approval to List Class A Subordinated Voting Shares on the Toronto Stock Exchange
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – The American Bar Association Asks Congress to Pass Legislation Allowing States to Enact Their Own Cannabis Laws
- ChineseInvestors.com (CIIX) Announces Sales Up 175% in Fiscal Year 2019
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Achieves Listing, Commences Trading on OTCQB Venture Market
- CloudCommerce (OTCQB: CLWD) Introduces SWARM Solution to Data-Driven Marketing
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Updated Reports Covering Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Subsidiary’s Home-Detection Kit Enables Women to Self-Screen for STIs
- Endonovo Therapeutics (OTCQB: ENDV) Planning Nationwide Rollout of Pain-Management Device
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Successfully Completes Controlled-Environment Trial for the Connected Car Division of a Leading Global Vehicle Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
- Geyser Brands Inc. (TSX.V: GYSR) Reports First-Quarter Financial Results, Updates on Solace Acquisition
- Grapefruit Boulevard Investments Inc. (IGNG) Engages Singer Lewak in 2018/2019 Audits
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Completes Private Placement of Units
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Thailand Turns Confiscated Marijuana into Medical Products
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Is ‘One to Watch’
- INmune Bio, Inc. (NASDAQ: INMB) to Present at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, September 10th at 2:10 p.m. ET
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Enhances Portfolio with VVG Acquisition
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery
- Marijuana Company of America Inc. (MCOAD) Completes Reverse Stock Split
- MustGrow Biologics Corp (CSE: MGRO) Obtains Exclusive Rights of Streptomyces Bio-Fungicide Product Used to Treat Powdery Mildew in Cannabis Production
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Announces Board Member Resignation
- Neutra Corp. (OTCQB: NTRR) CEO Sydney Jim Discusses Pain Management, CBD Purity and Becoming Vertically Integrated in the Hemp Industry
- Nightfood, Inc. (OTCQB: NGTF) Delivers Update on Recent Activities and Developments
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Gains Media Attention Following Four Profitable Quarters
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Positive Progress for its Vernal, Utah Plant Re-Engineering
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th
- Predictive Oncology Inc. (NASDAQ: POAI) Why POAI Is ‘One to Watch’
- Pressure BioSciences Inc. (PBIO) InvestmentPitch Media Video Discusses Pressure BioSciences' Two Purchase Orders for its Revolutionary BaroShear(tm) K45 Processing System for CBD Nanoemulsion - Video Available on Investmentpitch.com
- Quest Patent Research Corp. (QPRC) Is ‘One to Watch’
- Sharing Services Global Corporation (SHRG) Adds Value to Management Team with New Appointments
- SinglePoint, Inc. (SING) to Present Hemp Cigarettes at National Association of Convenience Stores (NACS) Exhibition, Over 23,000 Attendees, Booth 5653
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Completes $3M Non-Brokered Private Placement; Announces Filing of Q2 Financials, Upcoming Conference Call
- Spectrum Global Solutions, Inc. (SGSI) Secures Key Contract Renewal with U.S. Tier-1 Carrier
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Adds Seasoned Beverage Executive Constantine Constandis to the Board of Directors
- SRAX Inc. (NASDAQ: SRAX) is “One to Watch”
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Announces Delivery of Phases 1 & 2, Begins Installation of Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Ideally Positioned to Benefit During U.S.-China Tariff Trade War
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Continues to Expand Global Footprint
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Strongly Positioned to Meet Growing Demand for Organic Cannabis
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) International Patent Application for TherOZap(TM) Enters National Phases in the US, Europe & Canada
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Releases Corporate Update
- Trxade Group Inc. (TRXD) Empowering Small, Independent Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Posts Q2 2019 Financial and Operating Results
- VPR Brands, LP (VPRB) 420 with CNW – Colombia Makes Progress as an International Medical Marijuana Industry Player
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Product Offerings as CBD Becomes Mainstream in the Wellness Industry
- Willow Biosciences Inc. (CSE: WLLW) Engages The Howard Group; Presenting at the 8th Annual Gateway Conference
- Youngevity International, Inc. (NASDAQ: YGYI) Khrysos Industries, Inc., a wholly owned subsidiary of Youngevity International Reveals State of the Art, Florida Based Hemp Processing and Manufacturing Facility
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.